CRI Liver Cancer Immunotherapy Clinical Trial Finder
Liver cancer needs new, more effective treatments to help the approximately 42,000 people in the United States who are diagnosed each year. The most common form of liver cancer is hepatocellular carcinoma (HCC), which may be caused by the hepatitis virus, cirrhosis, obesity, or diabetes.
Clinical trials offer cutting-edge therapies to patients with liver cancer, including cancer immunotherapy, which harnesses and enhances the innate powers of the immune system to fight cancerous tumors.
The Cancer Research Institute has partnered with EmergingMed to provide the Liver Cancer Immunotherapy Clinical Trial Finder. Call now or fill out the form on the right to identify immunotherapy clinical trials that match your specific diagnosis, treatment history, and genomic profile. The service is completely free and confidential to patients